Blog
RSS FeedPosted by Michael Wonder on 10 Mar 2023
Medicare will take R&D costs, effectiveness into account when it negotiates drug prices. But studies show that doesn’t affect prices.
10 March 2023 - By law, Medicare will have to take a medication’s efficacy and its research and development costs ...
Posted by Michael Wonder on 29 Sep 2022
Europe's generic drugmakers say they may cut output due to energy bills
28 September 2022 - Europe's drugmakers have warned they may stop making some cheap generic medicines because of surging electricity ...
Posted by Michael Wonder on 24 Sep 2022
Prostate cancer: Tauranga man spends $212,000 on treatment
24 September 2022 - Five thousand and five hundred dollars every 28 days - more than $200,000 so far. ...
Posted by Michael Wonder on 28 Jul 2022
To promote innovation, Congress and companies should support drug development cost disclosure
28 July 2022 - Congress should pass the proposed Pharmaceutical Research Transparency Act of 2022 to mandate drug companies provide ...
Posted by Michael Wonder on 06 Jul 2021
Costco could have saved Medicare $2.6 billion in drug spending, analysis shows
6 July 2021 - Medicare spent billions more money on generic drugs for its beneficiaries than warehouse chain Costco did ...
Posted by Michael Wonder on 29 Jun 2021
Walmart unveils low-price insulin as more patients with diabetes struggle to pay for drug
29 June 2021 - The company has made a bigger push into health care as it tries to leverage its massive ...
Posted by Michael Wonder on 26 Apr 2021
Hospital costs, not drug prices, are out of control
26 April 2021 - Now that we have a steady supply of COVID-19 vaccines that will allow for all Americans to ...
Posted by Michael Wonder on 22 Oct 2020
$10,000 on new drugs every four months keeps melanoma patient alive
21 October 2020 - Graham Venning was given “weeks perhaps months” to live at the start of the year but ...
Posted by Michael Wonder on 17 Jun 2020
Most coronavirus tests cost about $100. Why did one cost $2,315?
16 June 2020 - U.S. health care prices are unregulated, opaque and unpredictable. When Congress required insurers to cover COVID-19 testing, ...
Posted by Michael Wonder on 15 Jun 2020
Rising costs explain why Canada is switching to biosimilars
15 June 2020 - Following in the footsteps of British Columbia, other Canadian provinces are working to implement their own biosimilars ...
Posted by Michael Wonder on 05 Mar 2020
Gene and cell therapies continue growth in patients, financing, and costs
5 March 2020 - The number of people treated with approved gene therapies and gene-modified cell therapies like CAR-T cancer ...
Posted by Michael Wonder on 03 Mar 2020
Extended-release drugs could be costing U.S. health care system billions
1 March 2020 - If doctors prescribed short-acting medications that must be taken twice a day instead of once-a-day extended-release ...
Posted by Michael Wonder on 06 Feb 2020
Call to reduce ‘scary’ gene therapy costs
28 November 2019 - Health care funders have been urged to overcome the “scary” cost of emerging gene therapies that ...
Posted by Michael Wonder on 29 Jan 2020
Drug prices to skyrocket with new health insurance company policy, according to Coalition of State Rheumatology Organizations
29 January 2020 - Coalition of State Rheumatology Organizations physicians are voicing concern for patients who will fall victim of ...
Posted by Michael Wonder on 28 Jan 2020
Big drug purchasers predict price hikes driven by expensive new therapies
27 January 2020 - More than two dozen big buyers of prescription medicines expect that prices will rise by an ...